| Cory Lee Middendorf, PHARMD | |
|
601 Jacob Ln, Anoka, MN 55303-1776 | |
| (763) 421-5540 | |
| (763) 421-9229 |
| Full Name | Cory Lee Middendorf |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 601 Jacob Ln, Anoka, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598117467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 122799 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cory Lee Middendorf, PHARMD 601 Jacob Ln, Anoka, MN 55303-1776 Ph: (763) 421-5540 | Cory Lee Middendorf, PHARMD 601 Jacob Ln, Anoka, MN 55303-1776 Ph: (763) 421-5540 |
News Archive
Eliminating bacteria's DNA and boosting antimicrobial proteins that already exist may help prevent middle ear infections from reoccurring. These are the findings from a Nationwide Children's Hospital study that examined how an immune defense protein common in the middle ear interacts with a structure meant to protect a colony of bacteria.
An effective vaccine against HIV-1 remains elusive, but one promising strategy focuses on designer antibodies that have much broader potency than most normal, exquisitely specific antibodies.
A study by UT Southwestern researchers finds that changing the biochemistry of parts of brain cells abolished the formation of amyloid beta plaques in a mouse model of Alzheimer's disease.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
Merck & Co. announced Monday that their experimental allergy tablet reduced allergic reactions to ragweed and helped patients use less medication to treat their symptoms.
› Verified 3 days ago
Alexi Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1911 S Ferry St, Anoka, MN 55303 Phone: 763-576-0388 | |
Carisa Lynn Finke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3301 7th Ave, Anoka, MN 55303 Phone: 651-431-5123 | |
Dr. Heidi Lee Holthus, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3605 Round Lake Blvd Nw, Anoka, MN 55303 Phone: 763-252-0751 | |
Amanda Marie Schroepfer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-421-5540 Fax: 763-421-9229 | |
Gordon A. Seim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Highway 10, Anoka, MN 55303 Phone: 763-427-7699 Fax: 763-712-8314 | |
Emily K Hulke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-421-5540 | |
Steven Thomas Simenson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Monroe St, Anoka, MN 55303 Phone: 763-421-5540 Fax: 763-421-9229 |